Regulators, ministries of health, policymakers and national pharmacy organisations are encouraged to assess regulations in their country related to pharmacy-based care of non-communicable diseases (NCDs) with a development tool developed by FIP’s Forum of Pharmacy Professional Regulators. This tool is based on experiences from countries where pharmacy services targeting NCDs (including testing, measurement of parameters, such as blood pressure and peak expiratory volume, and prescribing or modifying prescriptions) have been successfully introduced and regulated, and on researched pharmacy practice legislation from around the world.
Management of non-communicable diseases: Regulatory self-assessment and development tool for transforming pharmacy practice
Page: diseases
Chronic respiratory diseases: A handbook for pharmacists (2022)
The United Nations Sustainable Development Goals prioritise universal health coverage (UHC) and commit to reducing the impact of non-communicable diseases (NCDs) as well as communicable diseases. This handbook is an important enabling tool to achieve those goals because it makes the case for the inclusion of care for chronic respiratory diseases (CRDs) as part of UHC and demonstrates the important role pharmacists have in achieving this.
Knowledge and skills reference guide for professional development in chronic respiratory diseases: A companion to the FIP chronic respiratory diseases handbook for pharmacists. (2022)
This knowledge and skills reference guide provides a comprehensive list of required knowledge and skills in pharmaceutical and related care to support pharmacists to develop, upskill and refresh knowledge in CRDs and related roles in pharmacy. The guide supplements the FIP handbook on CRDs for pharmacists and was developed in consultation with a global reference group.
Indoor air pollution and health: causes, management and self-care approaches
Overall Aim:
To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them provide better patient advice and self-care.
Learning objectives:
• Identify the sources of indoor air pollution and its increasing threat to health
• Understand the short- and long-term impact of indoor air pollution particularly on children
• Understand clinical, pharmacological, and non-pharmacological treatments including self-care measures to minimize the impact of air pollution on respiratory health
• Illustrate how advocacy can impact behavior change to support adoption of better self-care practices aimed at reducing health impact of air pollution.
Moderator:
– Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia
Facilitator:
– Nour Eltahla, FIP Projects Coordinator for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia
Panelists:
– Lidia Morawska, Director International Laboratory for Air Quality and Health (WHO CC for Air Quality and Health), Queensland University of Technology, Australia
– Gary WK Wong, Professor and honorary consultant, Department of Paediatrics, Chinese University of Hong Kong, Hong Kong
– Tyler Knowlton, Director of Communications, Communities, and Partnerships Plume Labs, France
The contribution of pharmacists in non-communicable diseases: Asthma and COPD
This webinar is the first in a series of 4 webinars exploring the contribution of pharmacists to improving the quality of life of individuals living with asthma and COPD.
Outdoor and indoor air pollution: short- and long-term impacts on health
Air pollution needs to be addressed urgently and not only as an environmental and ecological threat, but also as a direct threat to health. This webinar describes the multiple ways in which air pollution can be harmful to health. Understanding such impacts is essential so that professional services and interventions by pharmacists can be developed to address this global threat.
Delivering asthma right care: For community pharmacists
Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine. Community pharmacy can be an important part of the asthma pathway and powerful change agents. This webinar will update on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You can hear from community pharmacists in the Asthma Right Care social movement about how to have impactful conversations about personal, national and international change and how to make it happen.
Delivering asthma right care: For hospital pharmacists
Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicines that can result in waste and harm including avoidable hospital attendances and admissions. Hospital pharmacists can be an important part of the asthma pathway and powerful change agents. This webinar provides updates on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You can hear from experts from the Asthma Right Care social movement about how to make impactful change happen in the provision of asthma care within secondary care settings.
Community pharmacy roles, services and tools to minimise impact of air pollution on health
Health systems and health care professionals are called upon to address and mitigate the impact of air pollution on people’s health and quality of life. This webinar provides examples of services that pharmacists can deliver to support better breathing.
Leveraging pharmacists to minimise the impact of air pollution on health: Policy barriers and drivers
There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium marks the 2021 United Nations’ International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.
